drugset / Trial / NCT04135677
Clinical Outcomes Between Anticoagulation and DAPT Therapy in AF Patients Successfully Undergoing LAAO
RandomizedParallel-groupTriple-blindPrevention
Summary
The objective of this study is to assess the efficacy and safety different dosage of rivaroxaban application versus dual antiplatelet therapy after successful closure of left atrial appendage using the LAMBRE device.
Timeline
- Start
- 2022-11-11
- Primary completion
- 2024-10-01
- Completion
- 2024-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 100 mg | — |
| Subject | Clopidogrel | Small molecule | 75 mg | — |
| Subject | Rivaroxaban | Other / unclassified | 20 mg | — |